2021 Fiscal Year Final Research Report
Development of an educational program for pharmacists to reduce stigma of mental illness with the aim of improving the quality of psychiatric care
| Project/Area Number |
19K07178
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 47060:Clinical pharmacy-related
|
|---|
| Research Institution | Meijo University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
半谷 眞七子 名城大学, 薬学部, 准教授 (40298568)
|
|---|
| Project Period (FY) |
2019-04-01 – 2022-03-31
|
| Keywords | スティグマ / 統合失調症 / 保険薬局薬剤師 / スティグマ評価尺度 / 教育プログラム |
|---|
| Outline of Final Research Achievements |
Stigma associated with mental disorders is rooted among many pharmacists, and represents a major barrier to patient support in community-based psychiatry. We developed an assessment scale that is specifically designed to assess the level of stigma that pharmacists may have toward schizophrenia, and then examined the effects of reducing stigma with an educational program that focuses on communication with patients diagnosed with schizophrenia (PDS) using the newly developed Stigma Scale towards Schizophrenia for Community Pharmacists (SSCP). Educational program-related changes of the total SSCP score from baseline showed a significant reduction of stigma levels in the contact-based intervention group. In conclusion, SSCP and the educational program for community pharmacists that focuses on communication with PDS were useful for assessing and reducing, respectively, the stigma attached by these pharmacists to schizophrenia.
|
| Free Research Field |
臨床精神薬学
|
| Academic Significance and Societal Importance of the Research Achievements |
本邦における統合失調症患者に対するスティグマは、一般市民だけでなく医療者のスティグマも依然として根強い。今後、統合失調症患者を取り巻く医療環境は、入院から外来中心にシフトし、薬剤師が統合失調症患者と接する機会が増大することから、そのスティグマを是正することが不可欠ある。しかし、これまで本邦において薬剤師のスティグマを是正する教育プログラムの報告はない。スティグマを是正するためには、講義のような啓発ではなく、患者との良好な接触体験が効果的である。本研究の取り組みにより、今後、地域包括ケアシステムの一翼として地域の保険薬局が機能し、精神疾患患者に効果的な回復をもたらすことができるものと考えられる。
|
